Le Lézard
Classified in: Health
Subjects: HEALTH, MISCELLANEOUS

Blood donors step up, but more still needed


OTTAWA, Dec. 27, 2017 (GLOBE NEWSWIRE) -- Canadian Blood Services has seen a notable increase in donations since Dec. 18 when it issued an urgent call for eligible donors to fill 35,000 open appointments by Jan. 6. However, more new and returning donors are still needed to help fill 18,000 open appointments.

"We are pleased so many Canadians have stepped up to fill open appointments to give blood and are confident others will join them by year-end or early in the New Year," says Rick Prinzen, Canadian Blood Services' Chief Supply Chain Officer.

The holiday season is a slower time for blood donations. Travel, family activities and changes in routines pose challenges to blood collections, especially the last half of December into the New Year.

"It can be tough during the holiday season to take an hour to give life but donors must continue to answer the call for blood, especially during the weeks of Dec. 25 and Jan. 1. Every donation is important and we still need donors to book appointments and, even more importantly, to keep them," says Prinzen.

While all blood types help patients, the supply of O-negative blood is in particular demand. Donors with O-negative blood are part of a select group whose donations are compatible with everyone. As the universal blood type, patients in an emergency situation can all receive O-negative blood.

Some blood collection centres will be open on New Year's Day, as well as during other regular collection hours. New and existing donors are welcome and walk-ins will continue to be accepted.

Canadians who are unable to give blood can give financially, and can encourage others in their networks to give blood on their behalf.

To book an appointment, download the GiveBlood app available for iOS on the App Store or for Android on Google Play, call 1 888 2 DONATE (1 888 236 6283), or visit blood.ca.

About Canadian Blood Services
Canadian Blood Services manages the national supply of blood, blood products and stem cells, and related services for all the provinces and territories (excluding Quebec). We operate an integrated, pan-Canadian service delivery model that includes leading an interprovincial system for organ donation and transplantation. Our national scope, infrastructure and governance make us unique in the Canadian healthcare landscape. Canadian Blood Services is regulated as a biologics manufacturer by Health Canada and primarily funded by the provincial and territorial ministries of health. Canadian Blood Services is a not-for-profit charitable organization.

ITSINYOUTOGIVE
@ITSINYOUTOGIVE
18882DONATE

FOR MORE INFORMATION
TEL. 1-877-709-7773
EMAIL [email protected]


These press releases may also interest you

at 16:10
Acadia Pharmaceuticals Inc. today announced that it will report first quarter financial results on Wednesday, May 8, 2024, after the close of the U.S. financial markets. Acadia's management team will also host a conference call and webcast on May 8,...

at 16:10
Pulse Biosciences, Inc. , a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablationtm (nsPFAtm) technology, today announced it will report financial results for the first quarter 2024 after market close on Tuesday, May...

at 16:05
BeiGene, Ltd. , a global oncology company, today announced it will share research outcomes from its broad hematology and solid tumor portfolio at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, May 31 - June 4, 2024....

at 16:05
Mundipharma* today announced the acquisition of all assets and rights related to rezafungin globally from Cidara Therapeutics. This provides Mundipharma with global ownership of rezafungin including ongoing development and distribution. Rezafungin...

at 16:05
Arrowhead Pharmaceuticals, Inc. today announced that it will host a webcast and conference call on May 9, 2024, at 4:30 p.m. ET to discuss its financial results for the fiscal second quarter ended March 31, 2024. Webcast and Conference Call and...

at 16:05
Arcus Biosciences, Inc. , a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, today announced three accepted abstracts at the 2024 American Society of...



News published on and distributed by: